<DOC>
	<DOCNO>NCT00001569</DOCNO>
	<brief_summary>Two day prior plan surgery , paclitaxel infuse IV 24 hour . Patients undergo cytoreductive surgery , debulk tumor . Scope procedure vary patient , include spectrum possible procedure , splenectomy , liver resection , pancreatic resection bowel resection . After cytoreductive surgery , continuous hyperthermic peritoneal perfusion ( CHPP ) surgery cisplatin begin place influx efflux catheter via abdominal wall . Perfusion rate cisplatin 1.5 L/min duration 90 min . Postoperative intraperitoneal chemotherapy begin 24 hour CHPP surgery . Dose escalation proceed patient give dose level receive 3 course . In order properly evaluate hematoxicity , minimum 3 week require dose escalation . MTD either dose level immediately level 2 6 patient cohort experience nonhematologic dose limit toxicity ( DLT ) 4 6 patient experience hematologic DLT . Two 4 month surgery , laparotomy conduct determine response treatment . If tumor size decrease , patient undergo second treatment course identical technique chemotherapy agent .</brief_summary>
	<brief_title>Phase I Trial Continuous Hyperthermic Peritoneal Perfusion ( CHPP ) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel 5-FU Peritoneal Carcinomatosis</brief_title>
	<detailed_description>Peritoneal carcinomatosis consider terminal stage tumor progression . Cytoreductive surgery plus aggressive combination intraperitoneal chemotherapy may significantly alter natural history disease . This study define maximum tolerate dose paclitaxel 5-fluorouracil ( 5-FU ) give early post-operative intraperitoneal ( IP ) dwell therapy cytoreductive surgery continuous hyperthermic peritoneal perfusion cisplatin ( CHPP ) .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>The patient must ECOG performance status 0 1 concomitant medical problem would place increase risk major surgical procedure ( EG , cardiac pulmonary disability ) . Patients increase risk coronary artery disease cardiac dysfunction ( e.g. , age great 65 , history hypertension , first degree relative atherosclerotic coronary artery disease ) undergo cardiac evaluation perform include attempt remove disease great 0.5 cm diameter .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>Gastrointestinal</keyword>
	<keyword>Adenocarcinoma</keyword>
	<keyword>Taxol</keyword>
</DOC>